One of the world’s first mRNA vaccines made Bancel a billionaire—and now the biotech CEO discusses his plans to use the mRNA breakthrough for cancer, genetic disorders, and even a better flu vaccine.
The cash pay company looks to offer a full stack primary care solution in lieu of traditional health insurance, including pharmacy distribution and in-home diagnostics.